反応式
O1CCCCC1[N:7]1[C:15]2[C:10](=[CH:11][C:12]([C:16]3[N:20]=[CH:19][N:18](C(C4C=CC=CC=4)(C4C=CC=CC=4)C4C=CC=CC=4)[N:17]=3)=[CH:13][CH:14]=2)[C:9]([C:40]2[CH:41]=[C:42]([NH:46][C:47](=[O:56])[CH:48]([CH:50]3[CH2:55][CH2:54][CH2:53][NH:52][CH2:51]3)[CH3:49])[CH:43]=[CH:44][CH:45]=2)=[N:8]1.Cl.C([O-])(O)=O.[Na+]>O1CCOCC1>[NH:18]1[CH:19]=[N:20][C:16]([C:12]2[CH:11]=[C:10]3[C:15](=[CH:14][CH:13]=2)[NH:7][N:8]=[C:9]3[C:40]2[CH:41]=[C:42]([NH:46][C:47](=[O:56])[CH:48]([CH:50]3[CH2:55][CH2:54][CH2:53][NH:52][CH2:51]3)[CH3:49])[CH:43]=[CH:44][CH:45]=2)=[N:17]1参加物
5
実験手順
N-(3-{1-Perhydro-2H-pyran-2-yl-5-[1-(triphenylmethyl)(1,2,4-triazol-3-yl)](1H-indazol-3-yl)}phenyl)-3-piperidylpropanamide was 4 mL of 4.0 N HCl in 1,4-dioxane. The reaction mixture was stirred at room temperature overnight. After neutralization with a saturated aqueous solution of NaHCO3, the crude reaction mixture was evaporated to dryness and purified by preparative HPLC (0.106 g, 38% yield over 2 steps): 1H NMR (CD3OD) δ 8.73 (br s, 1H), 8.35 (br s, 1H), 8.17 (t, 1H), 8.1 (dd, 1H), 7.7–7.6 (m, 3H), 7.5 (t, 1H), 2.8 (t, 2H), 2.66 (t, 2H), 2.58 (br s, 4H), 1.65 (m, 4H), 1.5 (m, 2H); ES-MS (m/z) 416 [M+H]+.
後処理
- customwas evaporated to dryness
- custompurified by preparative HPLC (0.106 g, 38% yield over 2 steps)
出典と根拠
- ORDレコード
- ord-2870d956387f4cec8dc376571abe37cf
- 出典データセット
- uspto-grants-2007_04
- 特許番号
- US07208513B2
関連ノート
読み込み中…